Luis Ortigosa del Castillo-rekin lankidetzan egindako argitalpenak (8)

2019

  1. Prospective longitudinal study: use of faecal gluten immunogenic peptides to monitor children diagnosed with coeliac disease during transition to a gluten-free diet

    Alimentary Pharmacology and Therapeutics, Vol. 49, Núm. 12, pp. 1484-1492

2018

  1. Increased prevalence of pathogenic bacteria in the gut microbiota of infants at risk of developing celiac disease: The PROFICEL study

    Gut Microbes, Vol. 9, Núm. 6, pp. 551-558

2016

  1. ESPGHAN 2012 guidelines for Coeliac disease diagnosis: Validation through a retrospective Spanish multicentric study

    Journal of Pediatric Gastroenterology and Nutrition, Vol. 62, Núm. 2, pp. 284-291

  2. Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients

    American Journal of Gastroenterology, Vol. 111, Núm. 10, pp. 1456-1465

2012

  1. Influence of milk-feeding type and genetic risk of developing coeliac disease on intestinal microbiota of infants: The PROFICEL study

    PLoS ONE, Vol. 7, Núm. 2

2011

  1. Influence of environmental and genetic factors linked to celiac disease risk on infant gut colonization by Bacteroides species

    Applied and Environmental Microbiology, Vol. 77, Núm. 15, pp. 5316-5323

2000

  1. A β-turn rich oats peptide as an antigen in an ELISA method for the screening of coeliac disease in a paediatric population

    European Journal of Clinical Investigation, Vol. 30, Núm. 8, pp. 702-708

1999

  1. A novel visual immunoassay for coeliac disease screening

    European Journal of Clinical Investigation, Vol. 29, Núm. 8, pp. 697-699